These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 741846)
1. [Chronic hepatitis as sequela of acute viral hepatitis A and hepatitis non A - non B (author's transl)]. Müller R; Willers H; Freise J; Höpken W Z Gastroenterol; 1978 Dec; 16(12):760-7. PubMed ID: 741846 [TBL] [Abstract][Full Text] [Related]
2. Virological and serological study in children hospitalized for acute hepatitis (detection of HBsAg, HAAg, anti-HAV and specific IgM-anti-HAV). Mavromichalis J; Skidmore S; Tsilikouna-Athanassiadou P; Sklavounou-Tsourouktsoglou S; Manios S Helv Paediatr Acta; 1981 Nov; 36(5):429-35. PubMed ID: 6796547 [TBL] [Abstract][Full Text] [Related]
3. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B. Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539 [TBL] [Abstract][Full Text] [Related]
4. [Epidemiology and prognosis of non-A, non-B hepatitis (author's transl)]. Müller R; Willers H; Knocke KW; Sipos S; Höpken W Dtsch Med Wochenschr; 1979 Oct; 104(42):1471-4. PubMed ID: 115667 [TBL] [Abstract][Full Text] [Related]
5. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses. Perrillo RP; Chau KH; Overby LR; Decker RH Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288 [TBL] [Abstract][Full Text] [Related]
6. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B. Niermeijer P; Gips CH; Huizenga JR; van der Waart M; Schuurs A Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369 [TBL] [Abstract][Full Text] [Related]
7. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]. Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain. Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155 [TBL] [Abstract][Full Text] [Related]
9. Anti-HCMV serologic response in patients with acute viral hepatitis. Stivala A; Guglielmino SP; Scalia G; Condorelli F; Ursino F; Castro A; Mughini MT; Cosentino S; Russo R New Microbiol; 1995 Oct; 18(4):423-6. PubMed ID: 8590395 [TBL] [Abstract][Full Text] [Related]
10. Role of delta infection in the progression to chronicity of acute HBsAg positive hepatitis. Caporaso N; del Vecchio-Blanco C; Servillo F; Suozzo R; Pignalosa G; Manzillo G; Maio G; Izzo CM; Coltorti M Gastroenterol Clin Biol; 1984; 8(8-9):646-50. PubMed ID: 6489684 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease. Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232 [TBL] [Abstract][Full Text] [Related]
12. Receptors for polymerized human serum albumin and other hepatitis B virus markers during acute hepatitis B--predictive value of the outcome of the disease. Mora I; Porres JC; Bartolome FJ; Hernandez Guio C; Gutiez J; Carreño V Hepatogastroenterology; 1986 Dec; 33(6):250-4. PubMed ID: 3026941 [TBL] [Abstract][Full Text] [Related]
13. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. Hussain Z; Das BC; Husain SA; Murthy NS; Kar P J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154 [TBL] [Abstract][Full Text] [Related]
14. [Antibodies against hepatitis B (surface) antigen in patients with hepatitis and other groups of epidemiologic interest (author's transl)]. Lange W; Apodaca J; Köhler H Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):199-212. PubMed ID: 1179881 [TBL] [Abstract][Full Text] [Related]
15. [Incidence of HAV and HBc antibodies in patients with chronic hepatitis]. Tanno H; Fay O; Roncoroni M; Galimberti B; Palazzi J Acta Gastroenterol Latinoam; 1980; 10(2):105-11. PubMed ID: 7211130 [TBL] [Abstract][Full Text] [Related]
16. [Hepatitis B and hepatitis A markers in 33 cases of acute hepatitis B surface antigen-negative, hepatitis A virus antibody-positive viral hepatitis. Importance of immune complexes]. Raise E; Bonazzi L; Cucci AM; Imbastaro T; Nucci S; Boni P; Miniero R; Lenzi G Minerva Med; 1982 Apr; 73(18):1169-72. PubMed ID: 6281689 [TBL] [Abstract][Full Text] [Related]
17. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B. Stránský J; Vodák M; Zichová M Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661 [TBL] [Abstract][Full Text] [Related]
18. Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Sagnelli E; Coppola N; Pisaturo M; Pisapia R; Onofrio M; Sagnelli C; Catuogno A; Scolastico C; Piccinino F; Filippini P Clin Infect Dis; 2006 Jun; 42(11):1536-43. PubMed ID: 16652310 [TBL] [Abstract][Full Text] [Related]